On 8 Oct 2026, NUOBIKAN (02635.HK) issued a placement supplement, earmarking proceeds for industrial AI O&M R&D and strategic buys; ~HKD 39.3mn available.
On 8 Oct 2026, XIN YUAN ENT (01748.HK) said ICBC International launched a conditional voluntary cash offer at HKD 2.21 per share, a 25.57% premium.
On 8 Oct 2026, LONGSYS (09976.HK) said H shares joined the Stock Connect (Shanghai/Shenzhen-Hong Kong) eligible list from 8 Oct, widening its base.
On 8 Oct 2026, CHINA CBS INTL (00989.HK) said the mandatory offer closed with 139,713 shares accepted (0.003%), for HKD 20,957; concert group at ~57.07%.
On 8 Oct 2026, JIU RONG HOLD (02358.HK) said a unit lost a land-lease suit, ordered to pay ~RMB 3.2mn and vacate; another faces a RMB 12.36mn bank claim.
On 8 Oct 2026, SUNSHINE PHARMA (06887.HK) won NMPA approval for its insulin degludec/aspart injection, taking its approved insulin range in China to 7.
On 8 Oct 2026, SERES (09927.HK) posted September NEV sales of 29,271 units (-34.48% YoY) and output of 28,387 (-37.55%); YTD sales 256,521 (-15.79%).
On 8 Oct 2026, HUARONG ENERGY (01101.HK) said Leung Yin Fai will resign as company secretary and authorised representative from 30 Oct, breaching Rule 3.28.
On 8 Oct 2026, CHANGHONG JH (03991.HK) declared an interim dividend of HKD 0.06 per share for the six months to 30 June, payable on 18 Dec; ex-date 30 Nov.
On 8 Oct 2026, SILKWAVE INC (00471.HK) signed an MOU with Thailand's Altura UAV on industrial drone R&D, manufacturing and market expansion; it is non-binding.
On 8 Oct 2026, KHOON GROUP (00924.HK) said it will not seek a review; its shares will be delisted at 9 a.m. on 13 Oct, with the last trading day on 12 Oct.
On 8 Oct 2026, GLMS SEC (01456.HK) said its controlling shareholder will add shares in 6 months, after the price fell below 80% of the RMB 11.17 issue price.
On 8 Oct 2026, LONGCHEER (09611.HK) filed three A-share notices: buybacks of 6.64mn shares for RMB 250mn YTD, a fund stake buy and a capital change.
On 8 October 2026, SSY GROUP (02005.HK) said it won NMPA production approval for nimodipine oral solution (10ml:60mg) in China, a Category 3 chemical drug.
On 8 October 2026, TAT HONG EQUIP (02153.HK) issued its 11th SDAX digital paper series at 4.65%, expecting to raise SGD 28m to SGD 33m for working capital.
On 8 October 2026, GIGADEVICE (03986.HK) said its September buyback of 789,600 A shares lifted cumulative repurchases to 2.4519m shares, or 0.35% of capital.
